Category Archives: Mesenchymal Stem Cells

Orange, CA (PRWEB) September 30, 2013 TeleHealth, the leading stem cell therapy clinic on the West Coast, is now offering multiple treatments with stem cells for knee arthritis. The stem cell treatments are very exciting as they present the possibility of repairing and regenerating arthritis damage in the knees. The treatments are offered by Board Certified stem cell doctors at the clinic in outpatient, low risk procedures that are often covered by insurance. Call (888) 828-4575 for more information and scheduling. Over the past few years, increasing studies are showing the benefits of regenerative medicine treatments for knee arthritis. This includes a study out of the Hospital for Special Surgery last year showing effectiveness of platelet rich plasma therapy for knee arthritis. Treatment options at TeleHealth include both platelet rich plasma therapy (PRP therapy) along with bone marrow derived stem cell injection therapy or fat derived stem cell therapy. Often, the treatments are combined to produce maximum knee arthritis benefit and allow patients to avoid surgery, reduce pain and dramatically increase functional ability. While knee replacement surgery has been shown to have a high success rate, the components are not meant to last forever and there can be complications with … Continue reading →

Jose Guzman began gasping for breath while using his treadmill on the lowest setting and knew something was wrong. His search for answers led him to the diagnosis of a rare lung disease with no cure. Guzman, 72, who arrived from Cuba penniless and built a thriving Miami travel agency, doesnt give up easily. He has signed on to be one of the first patients to participate in a clinical trial being launched at the University of Miami. Dr. Marilyn Glassberg has obtained approval from the Food and Drug Administration to launch the first U.S. clinical trial that will test whether mesenchymal stem cells given intravenously could be a therapy for patients with Guzmans rare lung disease, known as idiopathic pulmonary fibrosis. The disease strikes mostly men who are 55 and older and ex-smokers. Glassberg, a pulmonologist and professor of medicine and surgery and director of the pulmonary division at the Interdisciplinary Stem Cell Institute at UMs Miller School of Medicine, has studied rare lung diseases for 20 years. She says this is her first real hope of extending or improving the lives of her patients who have this progressive and fatal lung disease, which often leads to death within … Continue reading →

Spinal Cord Injury patient demonstrates progress after treatment at Stem Cell Institute Panama Watch towards the end to see Daniel demonstrate something his doctors told him he would never do. Daniel W suffered a T-8 complete spinal cord injury about 6... By: http://www.cellmedicine.com … Continue reading →

Stem cell repair of cartilage http://www.stemcellsarthritistreatment.com Two major types of cells are responsible for repair in the body. The hematopoietic stem cells which are responsibl... By: Nathan Wei … Continue reading →

Kilian Receives Stemlogix Stem Cell Therapy By: Stemlogix, LLC … Continue reading →

Ben Moody of Evanescence talks HGH Stem Cell Therapy MetroMD Los Angeles By: CARLY SMITHSON … Continue reading →

In a step that brings stem cells closer to the clinic, researchers in Japan have found that transplanting reprogrammed stem cells into the brains of primates elicits little rejection by their immune systems. Induced pluripotent stem cells (iPSCs) are created when skin cells, for example, are genetically reprogrammed to an embryonic-like state. This kind of stem cells holds great potential for the treatment of disease, since the cells are genetically identical to the patient they are taken from. However, studies in rodents have suggested that the immune system may still recognize cells derived from iPSCs as foreign, and mount an attack on them. This has cast doubt on the feasibility of similar cell therapy for humans. To test this in an animal more closely related to humans, researchers studied macaques. Using cells taken from the monkeys mouths or from their bloodstream, the researchers created iPSCs which they then, in turn, transformed into neurons. These neurons were of a specific kind: dopamine-producing neurons, the type depleted by Parkinsons disease. Each monkey got six injections of these neurons into its brainsome which had been made from their own cells and others which were from another individual and therefore mismatched. The team could … Continue reading →

COLUMBIA, Md.--(BUSINESS WIRE)-- Osiris Therapeutics, Inc. (OSIR), announced today that data from seven studies will be presented at the 2013 Fall Symposium on Advanced Wound Care (SAWC) in Las Vegas. The information presented will range from basic mechanistic science through human clinical trials. The healing potential of Grafix will be described in three of the abstracts by comparing the angiogenic, anti-inflammatory, and antioxidant effects of the cellular repair matrix to those of acellular human repair matrices (LB-136, LB-137 and LB-138). Additionally, four studies detailing the results of Grafix in various clinical settings will be presented, including the treatment of diabetic foot ulcers, venous leg ulcers and chronic wounds in patients undergoing long-term treatment with corticosteroids (CS-054, CS-060, CS-061 and Session 1 Presentation). Osiris has been conducting cutting edge research in cell therapy for more than 20 years, providing us with scientific insight that no other company in the space can match, said Michelle LeRoux Williams, Ph.D., Chief Scientific Officer. Our deep understanding of the science enables us to offer our physicians and patients the highest quality products, tested to the most rigorous standards and designed to achieve the best possible outcomes. The conference will feature a podium presentation by Dr. … Continue reading →

DGAP-News: Vita 34 AG / Key word(s): Miscellaneous Vita 34 AG: Expansion of Product Range with Permit for Collecting Umbilical Cord Tissue 26.09.2013 / 08:01 --------------------------------------------------------------------- Vita 34 AG: Expansion of Product Range with Permit for Collecting Umbilical Cord Tissue - Unique characteristic: Vita 34 is the only company in Germany that can store umbilical cord tissue along with umbilical cord blood - The storage of umbilical cord tissue offers additional sales and revenue potential for Vita 34 Leipzig, 26 September 2013 - Vita 34 AG (WKN A0BL84), Europe's oldest private stem cell bank and a specialist for cryo-preservation, has been granted a permit for collecting umbilical cord tissue in Saxony. Back in May 2013 Vita 34 had already received permission for the processing, cryo-preservation and storage of umbilical cord blood, after a successful inspection on the part of the State Direction Saxony and the Paul Ehrlich Institute. In accordance with the permit for collecting umbilical cord blood just granted in line with 20b German Pharmaceuticals Act, Vita 34 is the only private stem cell bank in Germany that can store not only umbilical cord blood, but also umbilical cord tissue according to Good Manufacturing Practice (GMP) guidelines, thus expanding … Continue reading →

Orange County, CA (PRWEB) September 23, 2013 The leading regenerative medicine clinic on the West Coast, TeleHealth, is now offering three different types of stem cell therapy injections. The California stem cell treatments are predominantly covered by insurance, and performed by Board Certified stem cell doctors. For more information and scheduling, call (888) 828-4575. The stem cell treatments are excellent for joint arthritis, tendonitis, ligament injuries, and spinal arthritis along with degenerative disc disease. Initial research with small studies has shown regenerative medicine treatments are working well for degenerative conditions, such as the recent study out of the Hospital for Special Surgery. One of the treatments offered is bone marrow derived stem cell injections. These are outpatient procedures that involve harvesting the patient's own bone marrow, processing it, and injecting into the area of concern at the same setting. These bone marrow stem cell injections have very low risk and the potential for helping regenerate damaged cartilage and soft tissue from such conditions as achilles tendonitis, rotator cuff tendonitis and tennis elbow. The second procedure offered is platelet rich plasma therapy. This procedure involves a simple blood draw from the patient, and the blood is centrifuged for approximately 15 minutes. … Continue reading →